1. First State China Growth Fund Class I (Accumulation) USD
Morningstar Category: China Equity
Morningstar Rating (2014-10-31):
2. ACMBernstein Asia Ex-Japan Equity Portfolio AD USD Inc
Morningstar Category: Asia ex Japan Equity
Morningstar Rating (2014-10-31):
3. BlackRock Global Funds - World Healthscience A2
Morningstar Category: Sector Equity Healthcare
Morningstar Rating (2014-10-31):
4. Schroder Asian Asset Income Fund USD A Income
Morningstar Category: Asia Allocation
Morningstar Rating (2014-10-31):
5. Allianz US High Yield AM USD
Morningstar Category: USD High Yield Bond
Morningstar Rating (2014-10-31):
6. ACMBernstein European Income Portfolio AT USD H
Morningstar Category: Other Bond
Morningstar Rating (2014-10-31): Not Rated
7. Legg Mason ClearBridge US Aggressive Growth Fund Class A USD Acc
Morningstar Category: US Large-Cap Growth Equity
Morningstar Rating (2014-10-31):
8. Templeton Global Total Return A Acc $
Morningstar Category: Global Bond
Morningstar Rating (2014-10-31):
9. Franklin Biotechnology Discovery A Acc $
Morningstar Category: Sector Equity Biotechnology
Morningstar Rating (2014-10-31):
10. ACMBernstein Global Value Portfolio AD USD Inc
Morningstar Category: Global Large-Cap Value Equity
Morningstar Rating (2014-10-31): Not Rated
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.
